We are live on !
Find out more
D.A. Davidson & Co Portfolio holdings
AUM
$18.6B
Turnover
10.32%
1-Year Est. Return
17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+17.65%
3 Year Est. Return
+78.37%
5 Year Est. Return
+81.49%
10 Year Est. Return
+246.08%
AUM
$5.1B
AUM Growth
+$669M
(+15%)
Cap. Flow
+$78.8M
Cap. Flow % of AUM
Cap. Flow %
1.55%
Top 10 Holdings %
Top 10 Hldgs %
26.48%
Holding
2,422
New
26
Increased
578
Reduced
364
Closed
1,380
Avg Time Held
3.3
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Value ETF
VTV
|
+$15.8M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$8.71M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.69M |
| 4 |
DuPont de Nemours
DD
|
+$8.15M |
| 5 |
Vanguard Morningstar Growth ETF
VUG
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$7.27M |
| 2 |
RTX Corp
RTX
|
+$4.97M |
| 3 |
Deere & Co
DE
|
+$4.85M |
| 4 |
Wells Fargo
WFC
|
+$4.74M |
| 5 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$4.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.08% |
| 2 | Technology | 8.3% |
| 3 | Healthcare | 8.24% |
| 4 | Financials | 7.45% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Vanguard Morningstar Value ETF
VTV
$197B
| $380M | 7.46% |
3,809,332
+161,607
| +4% | +$15.8M |
2013 Q2
17 quarters
|
|
|
2
Vanguard Morningstar Growth ETF
VUG
$219B
| $270M | 5.29% |
12,181,686
+343,596
| +3% | +$7.47M |
2013 Q2
17 quarters
|
|
|
3
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $228M | 4.48% |
5,255,319
+205,213
| +4% | +$8.71M |
2013 Q2
17 quarters
|
|
|
4
iShares Core US Aggregate Bond ETF
AGG
$137B
| $86.3M | 1.69% |
787,483
+79,121
| +11% | +$8.69M |
2013 Q2
17 quarters
|
|
5
Apple
AAPL
$5.18T
| $70.3M | 1.38% |
1,823,644
+9,112
| +0.5% | +$353K |
2013 Q2
17 quarters
|
|
6
Johnson & Johnson
JNJ
$688B
| $70M | 1.37% |
538,338
+2,937
| +0.5% | +$389K |
2013 Q2
17 quarters
|
|
7
Microsoft
MSFT
$3.89T
| $69.2M | 1.36% |
928,657
-5,552
| -0.6% | -$406K |
2013 Q2
17 quarters
|
|
8
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $66.2M | 1.3% |
1,255,898
+15,820
| +1% | +$818K |
2013 Q2
17 quarters
|
|
9
AT&T
T
$149B
| $55.7M | 1.09% |
1,881,335
+122,972
| +7% | +$3.49M |
2013 Q2
17 quarters
|
|
10
CVS Health
CVS
$114B
| $54.2M | 1.06% |
666,318
+45,983
| +7% | +$3.64M |
2013 Q2
17 quarters
|
|
11
ExxonMobil
XOM
$696B
| $52.9M | 1.04% |
645,211
+46,776
| +8% | +$3.71M |
2013 Q2
17 quarters
|
|
12
iShares Russell 2000 Value ETF
IWN
$14B
| $50.7M | 0.99% |
408,451
+25,805
| +7% | +$3.04M |
2013 Q2
17 quarters
|
|
13
Procter & Gamble
PG
$394B
| $49.9M | 0.98% |
548,838
+24,344
| +5% | +$2.22M |
2013 Q2
17 quarters
|
|
14
Berkshire Hathaway Class B
BRK.B
$1.26T
| $44.8M | 0.88% |
244,134
-10,038
| -4% | -$1.77M |
2013 Q2
17 quarters
|
|
15
PepsiCo
PEP
$198B
| $44.7M | 0.88% |
401,019
+2,102
| +0.5% | +$243K |
2013 Q2
17 quarters
|
|
16
Novartis
NVS
$303B
| $44.3M | 0.87% |
576,000
+3,769
| +0.7% | +$285K |
2013 Q2
17 quarters
|
|
|
17
RTX Corp
RTX
$268B
| $44M | 0.86% |
602,547
-67,115
| -10% | -$4.97M |
2013 Q2
17 quarters
|
|
18
iShares Russell 2000 Growth ETF
IWO
$13.9B
| $43.7M | 0.86% |
244,247
+11,344
| +5% | +$1.93M |
2013 Q2
17 quarters
|
|
19
iShares Russell 1000 Growth ETF
IWF
$118B
| $43.6M | 0.86% |
1,396,112
+23,988
| +2% | +$734K |
2013 Q2
17 quarters
|
|
20
Chubb
CB
$144B
| $43.1M | 0.85% |
302,495
+7,908
| +3% | +$1.14M |
2013 Q2
17 quarters
|
|
21
Vanguard Short-Term Bond ETF
BSV
$46.5B
| $43M | 0.84% |
539,183
+51,322
| +11% | +$4.1M |
2013 Q2
17 quarters
|
|
22
VF Corp
VFC
$8.14B
| $42.6M | 0.84% |
712,095
+15,247
| +2% | +$880K |
2013 Q2
17 quarters
|
|
23
IBM
IBM
$234B
| $42.2M | 0.83% |
303,970
+24,186
| +9% | +$3.37M |
2013 Q2
17 quarters
|
|
24
iShares Core S&P 500 ETF
IVV
$875B
| $40.2M | 0.79% |
158,848
+2,784
| +2% | +$691K |
2013 Q2
17 quarters
|
|
25
Visa
V
$794B
| $37.6M | 0.74% |
357,125
-11,686
| -3% | -$1.19M |
2013 Q2
17 quarters
|
|
Similar funds
D.A. Davidson & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.A. Davidson & Co held 2,422 positions worth $5.1B, up 15% from $4.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
D.A. Davidson & Co's Q3 2017 filing shows 26 new, 578 increased, 364 reduced and 1,380 closed positions. Its largest new stake was iShares Core 5-10 Year USD Bond ETF: 70,969 shares worth $3.53M. The largest sale was Du Pont De Nemours E I, an estimated $7.27M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.
- D.A. Davidson & Co's largest Q3 2017 buy was iShares Core 5-10 Year USD Bond ETF: 70,969 shares worth $3.53M.
- D.A. Davidson & Co added most to Vanguard Morningstar Value ETF in Q3 2017, an estimated $15.8M increase.
- D.A. Davidson & Co's biggest Q3 2017 reduction was RTX Corp, cutting an estimated $4.97M.
- D.A. Davidson & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $7.27M.
- D.A. Davidson & Co's ten largest holdings make up 26% of its $5.1B portfolio in Q3 2017.
- D.A. Davidson & Co opened 26 new positions and closed 1,380 in Q3 2017.
- D.A. Davidson & Co's portfolio value rose 15% quarter-over-quarter to $5.1B.
Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.